Regional differences of insulin action in adipose tissue: Insights from in vivo and in vitro studies

Acta Physiologica Scandinavica

Volumn 183, Issue 1, 2005, Pages 13-30

  Giorgino, Francesco ^a   Laviola, L ^a   Eriksson, J W ^b,c  

^a UNIVERSITY OF BARI   (Italy)

^b UMEÅ UNIVERSITY HOSPITAL   (Sweden)

^c ASTRAZENECA R AND D   (Sweden)

Author keywords

Catecholamines; Glucocorticoids; Glucose turnover; Insulin; Lipolysis; Omental fat; Signalling; Subcutaneous fat; Visceral fat

Indexed keywords

CATECHOLAMINE DERIVATIVE; INSULIN; TRIACYLGLYCEROL;

ADIPOCYTE; ADIPOSE TISSUE; BODY FAT; CARDIOVASCULAR DISEASE; DISEASE ASSOCIATION; DYSLIPIDEMIA; ENERGY BALANCE; HOMEOSTASIS; HORMONE ACTION; HUMAN; HUMAN TISSUE; HYPERTENSION; IN VITRO STUDY; IN VIVO STUDY; INSULIN RESISTANCE; METABOLIC REGULATION; NON INSULIN DEPENDENT DIABETES MELLITUS; OBESITY; PARACRINE SIGNALING; PRIORITY JOURNAL; PROTEIN CONTENT; REGULATORY MECHANISM; REVIEW; RISK ASSESSMENT; SIGNAL TRANSDUCTION;

ADIPOCYTES; ADIPOSE TISSUE; AUTONOMIC NERVOUS SYSTEM; CATECHOLAMINES; DIABETES MELLITUS, TYPE 2; GLUCOCORTICOIDS; GLUCOSE; HUMANS; INSULIN; INSULIN RESISTANCE; LIPIDS; LIPOLYSIS; SIGNAL TRANSDUCTION;

EID: 13244279594     PISSN: 00016772     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1365-201X.2004.01385.x     Document Type: Review

References (188)

1. Abel, E.D., Peroni, O., Kim, J.K. et al. 2001. Adipose-selective targeting of the GLUT4 gene impairs insulin action in muscle and liver. Nature 409, 729-733.
2. Adams, M., Montague, C.T., Prins, J.B. et al. 1997. Activators of peroxisome proliferator-activated receptor gamma have depot-specific effects on human preadipocyte differentiation. J Clin Invest 100, 3149-3153.
3. Ahima, R.S. & Flier, J.S. 2000. Adipose tissue as an endocrine organ. Trends Endocrinol Metab 11, 327-332.
4. Aldhahi, W., Mun, E. & Goldfine, A.B. 2004. Portal and peripheral cortisol levels in obese humans. Diabetologia 47, 833-836.
5. Alessi, D.R. & Downes, C.P. 1998. The role of PI 3-kinase in insulin action. Biochem Biophys Acta 1436, 151-164.
6. Alessi, D.R., James, S.R., Downes, C.P. et al. 1997. Characterization of a 3-phosphoinositide-dependent protein kinase which phosphorylates and activates protein kinase Balpha. Curr Biol 7, 261-269.
7. Arita, Y., Kihara, S., Ouchi, N. et al. 1999. Paradoxical decrease of an adipose-specific protein, adiponectin, in obesity. Biochem Biophys Res Commun 257, 79-83.
8. Arner, P. 1993. Adenosine, prostaglandins and phosphodiesterase as targets for obesity pharmacotherapy. Int J Obes Relat Metab Disord 17(Suppl. 1), S57-S59.
9. Arner, P., Bolinder, J., Engfeldt, P. & Ostman, J. 1981. The antilipolytic effect of insulin in human adipose tissue in obesity, diabetes mellitus, hyperinsulinemia, and starvation. Metabolism 30, 753-760.
10. Arner, P., Hellstrom, L., Wahrenberg, H. & Bronnegard, M. 1990. Beta-adrenoceptor expression in human fat cells from different regions. J Clin Invest 86, 1595-1600.
11. Azzout-Marniche, D., Becard, D., Guichard, C., Foretz, M., Ferre, P. & Foufelle, F. 2000. Insulin effects on sterol regulatory-element-binding protein-1c (SREBP-1c) transcriptional activity in rat hepatocytes. Biochem J 350, 389-393.
12. Bandyopadhyay, G., Standaert, M.L., Zhao, L. et al. 1997. Activation of protein kinase C (alpha, beta, and zeta) by insulin in 3T3/L1 cells. J Biol Chem 272, 2551-2558.
13. Bandyopadhyay, G., Standaert, M.L., Sajan, M.P. et al. 1999. Dependence of insulin-stimulated glucose transporter 4 translocation on 3-phosphoinositide-dependent protein kinase-1 and its target threonine-410 in the activation loop of protein kinase C-zeta. Mol Endocrinol 13, 1766-1772.
14. Bandyopadhyay, G., Sajan, M.P., Kanoh, Y. et al. 2002. PKC-zeta mediates insulin effects on glucose transport in cultured preadipocyte-derived human adipocytes. J Clin Endocrinol Metab 87, 716-723.
15. Barbe, P., Millet, L., Galitzky, J., Lafontan, M. & Berlan, M. 1996. In situ assessment of the role of the beta 1-, beta 2- and beta 3-adrenoceptors in the control of lipolysis and nutritive blood flow in human subcutaneous adipose tissue. Br J Pharmacol 117, 907-913.
16. Bastelica, D., Morange, P., Berthet, B. et al. 2002. Strornal cells are the main plasminogen activator inhibitor-1-producing cells in human fat: evidence of differences between visceral and subcutaneous deposits. Arterioscler Thromb Vasc Biol 22, 173-178.
17. Baumann, C.A., Ribon, V., Kanzaki, M. et al. 2000. CAP defines a second signalling pathway required for insulin-stimulated glucose transport. Nature 407, 202-207.
18. Belfrage, P., Fredrikson, G., Nilsson, N.O. & Stralfors, P. 1981. Regulation of adipose-tissue lipolysis by phosphorylation of hormone-sensitive lipase. Int J Obes 5, 635-641.
19. Berg, A.H., Combs, T.P., Du, X., Brownlee, M. & Scherer, P.E. 2001. The adipocyte-secreted protein Acrp30 enhances hepatic insulin action. Nat Med 7, 947-953.
20. Bergstrom, R.W., Newell-Morris, L.L., Leonetti, D.L., Shuman, W.P., Wahl, P.W. & Fujimoto, W.Y. 1990. Association of elevated fasting C-peptide level and increased intra-abdominal fat distribution with development of NIDDM in Japanese-American men. Diabetes 39, 104-111.
21. Boden, G. 1998. Free fatty acids (FFA), a link between obesity and insulin resistance. Front Biosci 3, D169-D175.
22. Boden, G. & Chen, X. 1995. Effects of fat on glucose uptake and utilization in patients with non-insulin-dependent diabetes. J Clin Invest 96, 1261-1268.
23. Boden, G. & Hoeldtke, R.D. 2003. Nerves, fat, and insulin resistance. N Engl J Med 349, 1966-1967.
24. Bolinder, J., Kager, L., Ostman, J. & Arner, P. 1983. Differences at the receptor and postreceptor levels between human omental and subcutaneous adipose tissue in the action of insulin on lipolysis. Diabetes 32, 117-123.
25. Boney, C.M., Gruppuso, P.A., Faris, R.A. & Frackelton, A.R. Jr 2000. The critical role of Shc in insulin-like growth factor-I-mediated mitogenesis and differentiation in 3T3-L1 preadipocytes. Mol Endocrinol 14, 805-813.
26. Bujalska, I.J., Kumar, S. & Stewart, P.M. 1997. Does central obesity reflect "Cushing's disease of the omentum"? Lancet 349, 1210-1213.
27. Buren, J., Lindmark, S., Renstrom, F. & Eriksson, J.W. 2003. In vitro reversal of hyperglycemia normalizes insulin action in fat cells from type 2 diabetes patients: is cellular insulin resistance caused by glucotoxicity in vivo? Metabolism 52, 239-245.
28. Cheatham, B. & Kahn, C.R. 1995. Insulin action and the insulin signaling network. Endocr Rev 16, 117-142.
29. Cheatham, B., Vlahos, C., Cheatham, L., Wang, L., Blenis, J. & Kahn, C. 1994. Phosphatidylinositol 3-kinase activation is required for insulin stimulation of pp70 S6 kinase, DNA synthesis, and glucose transporter translocation. Mol Cell Biol 14, 4902-4911.
30. Chiang, S.H., Baumann, C.A., Kanzaki, M. et al. 2001. Insulin-stimulated GLUT4 translocation requires the CAP-dependent activation of TC10. Nature 410, 944-948.
31. Clarke, J.F., Young, P.W., Yonezawa, K., Kasuga, M. & Holman, G.D. 1994. Inhibition of the translocation of GLUT1 and GLUT4 in 3T3-L1 cells by the phosphatidylinositol 3-kinase inhibitor, wortmannin. Biochem J 300, 631-635.
32. Clement, S., Krause, U., Desmedt, F. et al. 2001. The lipid phosphatase SHIP2 controls insulin sensitivity. Nature 409, 92-97.
33. Cong, L.-N., Chen, H., Li, Y. et al. 1997. Physiological role of Akt in insulin-stimulated translocation of GLUT4 in transfected rat adipose cells. Mol Endocrinol 11, 1881-1890.
34. Coppack, S.W. 2001. Pro-inflammatory cytokines and adipose tissue. Proc Nutr Soc 60, 349-356.
35. Curat, C.A., Miranville, A., Sengenes, C. et al. 2004. From blood monocytes to adipose tissue-resident macrophages: induction of diapedesis by human mature adipocytes. Diabetes 53, 1285-1292.
36. Dandona, P., Weinstock, R., Thusu, K., Abdel-Rahman, E., Aljada, A. & Wadden, T. 1998. Tumor necrosis factor-alpha in sera of obese patients: fall with weight loss. J Clin Endocrinol Metab 83, 2907-2910.
37. Davis, R.J., Corvera, S. & Czech, M.P. 1986. Insulin stimulates cellular iron uptake and causes the redistribution of intracellular transferrin receptors to the plasma membrane. J Biol Chem 261, 8708-8711.
38. Degerman, E., Smith, C.J., Tornqvist, H., Vasta, V., Belfrage, P. & Manganiello, V.C. 1990. Evidence that insulin and isoprenaline activate the cGMP-inhibited low-Km cAMP phosphodiesterase in rat fat cells by phosphorylation. Proc Natl Acad Sci USA 87, 533-537.
39. Degerman, E., Belfrage, P. & Manganiello, V.C. 1997. Structure, localization, and regulation of cGMP-inhibited phosphodiesterase (PDE3). J Biol Chem 272, 6823-6826.
40. Delaunay, F., Khan, A., Cintra, A. et al. 1997. Pancreatic beta cells are important targets for the diabetogenic effects of glucocorticoids. J Clin Invest 100, 2094-2098.
41. Despres, J.P. 2001. Health consequences of visceral obesity. Ann Med 33, 534-541.
42. Dietze, D., Koenen, M., Rohrig, K., Horikoshi, H., Hauner, H. & Eckel, J. 2002. Impairment of insulin signaling in human skeletal muscle cells by co-culture with human adipocytes. Diabetes 51, 2369-2376.
43. Diraison, F., Yankah, V., Letexier, D., Dusserre, E., Jones, P. & Beylot, M. 2003. Differences in the regulation of adipose tissue and liver lipogenesis by carbohydrates in humans. J Lipid Res 44, 846-853.
44. El-Haschimi, K. & Lehnert, H. 2003. Leptin resistance - or why leptin fails to work in obesity. Exp Clin Endocrinol Diabetes 111, 2-7.
45. Engfeldt, P., Hellmer, J., Wahrenberg, H. & Arner, P. 1988. Effects of insulin on adrenoceptor binding and the rate of catecholamine-induced lipolysis in isolated human fat cells. J Biol Chem 263, 15553-15560.
46. Eriksson, J.W., Smith, U., Waagstein, F., Wysocki, M. & Jansson, P.A. 1999. Glucose turnover and adipose tissue lipolysis are insulin-resistant in healthy relatives of type 2 diabetes patients: is cellular insulin resistance a secondary phenomenon? Diabetes 48, 1572-1578.
47. Evans, D.J., Hoffmann, R.G., Kalkhoff, R.K. & Kissebah, A.H. 1984. Relationship of body fat topography to insulin sensitivity and metabolic profiles in premenopausal women. Metabolism 33, 68-75.
48. Fain, J.N., Madan, A.K., Hiler, M.L., Cheema, P. & Bahouth, S.W. 2004. Comparison of the release of adipokines by adipose tissue, adipose tissue matrix, and adipocytes from visceral and subcutaneous abdominal adipose tissues of obese humans. Endocrinology 145, 2273-2282.
49. Fasshauer, M. & Paschke, R. 2003. Regulation of adipocytokines and insulin resistance. Diabetologia 46, 1594-1603.
50. Feinstein, R., Kanety, H., Papa, M.Z., Lunenfeld, B. & Karasik, A. 1993. Tumor necrosis factor-alpha suppresses insulin-induced tyrosine phosphorylation of insulin receptor and its substrates. J Biol Chem 268, 26055-26058.
51. Fletcher, L.M., Welsh, G.I., Oatey, P.B. & Tavare, J.M. 2000. Role for the microtubule cytoskeleton in GLUT4 vesicle trafficking and in the regulation of insulin-stimulated glucose uptake. Biochem J 352, 267-276.
52. Fliers, E., Kreier, F., Voshol, P.J. et al. 2003. White adipose tissue: getting nervous. J Neuroendocrinol 15, 1005-1010.
53. Foretz, M., Pacot, C., Dugail, I. et al. 1999a. ADD1/SREBP-1c is required in the activation of hepatic lipogenic gene expression by glucose. Mol Cell Biol 19, 3760-3768.
54. Foretz, M., Guichard, C., Ferre, P. & Foufelle, F. 1999b. Sterol regulatory element binding protein-1c is a major mediator of insulin action on the hepatic expression of glucokinase and lipogenesis-related genes. Proc Natl Acad Sci USA 96, 12737-12742.
55. Frayn, K.N. 2000. Visceral fat and insulin resistance - causative or correlative? Br J Nutr 83(Suppl. 1), S71-S77.
56. Fried, S.K., Russell, C.D., Grauso, N.L. & Brolin, R.E. 1993. Lipoprotein lipase regulation by insulin and glucocorticoid in subcutaneous and omental adipose tissues of obese women and men. J Clin Invest 92, 2191-2198.
57. Fried, S.K., Bunkin, D.A. & Greenberg, A.S. 1998. Omental and subcutaneous adipose tissues of obese subjects release interleukin-6: depot difference and regulation by glucocorticoid. J Clin Endocrinol Metab 83, 847-850.
58. Fruebis, J., Tsao, T.S., Javorschi, S. et al. 2001. Proteolytic cleavage product of 30-kDa adipocyte complement-related protein increases fatty acid oxidation in muscle and causes weight loss in mice. Proc Natl Acad Sci USA 98, 2005-2010.
59. Gabriely, I. & Barzilai, N. 2003. Surgical removal of visceral adipose tissue: effects on insulin action. Curr Diab Rep 3, 201-206.
60. Gabriely, I., Ma, X.H., Yang, X.M. et al. 2002. Removal of visceral fat prevents insulin resistance and glucose intolerance of aging: an adipokine-mediated process? Diabetes 51, 2951-2958.
61. Gautier, J.F., Milner, M.R., Elam, E., Chen, K., Ravussin, E. & Pratley, R.E. 1999. Visceral adipose tissue is not increased in Pima Indians compared with equally obese Caucasians and is not related to insulin action or secretion. Diabetologia 42, 28-34.
62. Grundy, S.M., Brewer, H.B. Jr, Cleeman, J.I., Smith, S.C. Jr & Lenfant, C. 2004. Definition of metabolic syndrome: Report of the National Heart, Lung, and Blood Institute/American Heart Association conference on scientific issues related to definition. Circulation 109, 433-438.
63. Guilherme, A., Emoto, M., Buxton, J.M. et al. 2000. Perinuclear localization and insulin responsiveness of GLUT4 requires cytoskeletal integrity in 3T3-L1 adipocytes. J Biol Chem 275, 38151-38159.
64. Hagstrom-Toft, E., Bolinder, J., Eriksson, S. & Arner, P. 1995. Role of phosphodiesterase III in the antilipolytic effect of insulin in vivo. Diabetes 44, 1170-1175.
65. Halleux, C.M., Takahashi, M., Delporte, M.L. et al. 2001. Secretion of adiponectin and regulation of apM1 gene expression in human visceral adipose tissue. Biochem Biophys Res Commun 288, 1102-1107.
66. Hansen, O., Johansson, B.W. & Nilsson-Ehle, P. 1990. Metabolic, electrocardiographic, and hemodynamic responses to increased circulating adrenaline: effects of selective and nonselective beta adrenoceptor blockade. Angiology 41, 175-188.
67. Hara, K., Yonezawa, K., Sakaue, H. et al. 1994. Phosphatidylinositol 3-kinase activity is required for insulin-stimulated glucose transport but not for RAS activation in CHO cells. Proc Natl Acad Sci USA 91, 7415-7419.
68. Havel, P.J. 2004. Update on adipocyte hormones: regulation of energy balance and carbohydrate/lipid metabolism. Diabetes 53(Suppl. 1), S143-S151.
69. Hotta, K., Funahashi, T., Arita, Y. et al. 2000. Plasma concentrations of a novel, adipose-specific protein, adiponectin, in type 2 diabetic patients. Arterioscler Thromb Vasc Biol 20, 1595-1599.
70. Illiano, G. & Cuatrecasas, P. 1972. Modulation of adenylate cyclase activity in liver and fat cell membranes by insulin. Science 175, 906-908.
71. Jensen, M.D. 1997. Lipolysis: contribution from regional fat. Annu Rev Nutr 17, 127-139.
72. Jensen, M.D., Cardin, S., Edgerton, D. & Cherrington, A. 2003. Splanchnic free fatty acid kinetics. Am J Physiol Endocrinol Metab 284, E1140-E1148.
73. Johanson, E.H., Jansson, P.A., Lonn, L. et al. 2003. Fat distribution, lipid accumulation in the liver, and exercise capacity do not explain the insulin resistance in healthy males with a family history for type 2 diabetes. J Clin Endocrinol Metab 88, 4232-4238.
74. Katome, T., Obata, T., Matsushima, R. et al. 2003. Use of RNA interference-mediated gene silencing and adenoviral overexpression to elucidate the roles of AKT/protein kinase B isoforms in insulin actions. J Biol Chem 278, 28312-28323.
75. Katsuki, A., Sumida, Y., Murashima, S. et al. 1998. Serum levels of tumor necrosis factor-alpha are increased in obese patients with noninsulin-dependent diabetes mellitus. J Clin Endocrinol Metab 83, 859-862.
76. Kelley, D.E., Goodpaster, B.H. & Storlien, L. 2002. Muscle triglyceride and insulin resistance. Annu Rev Nutr 22, 325-346.
77. Kim, J.B. & Spiegelman, B.M. 1996. ADD1/SREBP1 promotes adipocyte differentiation and gene expression linked to fatty acid metabolism. Genes Dev 10, 1096-1107.
78. Kim, J.B., Sarraf, P., Wright, M. et al. 1998. Nutritional and insulin regulation of fatty acid synthetase and leptin gene expression through ADD1/SREBP1. J Clin Invest 101, 1-9.
79. Kissebah, A.H., Vydelingum, N., Murray, R. et al. 1982. Relation of body fat distribution to metabolic complications of obesity. J Clin Endocrinol Metab 54, 254-260.
80. Kitamura, T., Ogawa, W., Sakaue, H. et al. 1998. Requirement for activation of the serine-threonine kinase Akt (protein kinase B) in insulin stimulation of protein synthesis but not of glucose transport. Mol Cell Biol 18, 3708-3717.
81. Kitamura, T., Kitamura, Y., Kuroda, S. et al. 1999. Insulin-induced phosphorylation and activation of cyclic nucleotide phosphodiesterase 3B by the serine-threonine kinase Akt. Mol Cell Biol 19, 6286-6296.
82. Klip, A. & Paquet, M.R. 1990. Glucose transport and glucose transporters in muscle and their metabolic regulation. Diabetes Care 13, 228-243.
83. Kohn, A.D., Summers, S.A., Birnbaum, M.J. & Roth, R.A. 1996. Expression of a constitutively active Akt Ser/Thr kinase in 3T3-L1 adipocytes stimulates glucose uptake and glucose transporter 4 translocation. J Biol Chem 271, 31372-31378.
84. Kotani, K., Ogawa, W., Matsumoto, M. et al. 1998. Requirement of atypical protein kinase Cλ for insulin stimulation of glucose uptake but not for Akt activation in 3T3-L1 adipocytes. Mol Cell Biol 18, 6971-6982.
85. Kreier, F., Fliers, E., Voshol, P.J. et al. 2002. Selective parasympathetic innervation of subcutaneous and intra-abdominal fat-functional implications. J Clin Invest 110, 1243-1250.
86. Kreier, F., Yilmaz, A., Kalsbeek, A. et al. 2003. Hypothesis: shifting the equilibrium from activity to food leads to autonomic unbalance and the metabolic syndrome. Diabetes 52, 2652-2656.
87. Lafontan, M. & Berlan, M. 1993. Fat cell adrenergic receptors and the control of white and brown fat cell function. J Lipid Res 34, 1057-1091.
88. Lavan, B.E., Lane, W.S. & Lienhard, G.E. 1997a. The 60-kDa phosphotyrosine protein in insulin-treated adipocytes is a new member of the insulin receptor substrate family. J Biol Chem 272, 11439-11443.
89. Lavan, B.E., Fantin, V.R., Chang, E.T., Lane, W.S., Keller, S.R. & Lienhard, G.E. 1997b. A novel 160-kDa phosphotyrosine protein in insulin-treated embryonic kidney cells is a new member of the insulin receptor substrate family. J Biol Chem 272, 21403-21407.
90. Le Lay, S., Lefrere, I., Trautwein, C., Dugail, I. & Krief, S. 2002. Insulin and sterol-regulatory element-binding protein-1c (SREBP-1C) regulation of gene expression in 3T3-L1 adipocytes. Identification of CCAAT/enhancer- binding protein beta as an SREBP-1C target. J Biol Chem 277, 35625-35634.
91. Lefebvre, A.M., Laville, M., Vega, N. et al. 1998. Depot-specific differences in adipose tissue gene expression in lean and obese subjects. Diabetes 47, 98-103.
92. Lindmark, S. 2004. Neurohormonal Mechanisms in Insulin Resistance and Type 2 Diabetes. Umea University Medical Dissertations, New series no 874. Umea University, Umea.
93. Lonn, L., Kvist, H., Ernest, I. & Sjostrom, L. 1994. Changes in body composition and adipose tissue distribution after treatment of women with Cushing's syndrome. Metabolism 43, 1517-1522.
94. Lonnqvist, F., Krief, S., Strosberg, A.D., Nyberg, S., Emorine, L.J. & Arner, P. 1993. Evidence for a functional beta 3-adrenoceptor in man. Br J Pharmacol 110, 929-936.
95. Lonnroth, P. & Smith, U. 1986. The antilipolytic effect of insulin in human adipocytes requires activation of the phosphodiesterase. Biochem Biophys Res Commun 141, 1157-1161.
96. Lundgren, M., Buren, J., Ruge, T., Myrnas, T. & Eriksson, J.W. 2004. Glucocorticoids down-regulate glucose uptake capacity and insulin-signaling proteins in omental but not subcutaneous human adipocytes. J Clin Endocrinol Metab 89, 2989-2997.
97. Maeda, N., Takahashi, M., Funahashi, T. et al. 2001. PPAR-gamma ligands increase expression and plasma concentrations of adiponectin, an adipose-derived protein. Diabetes 50, 2094-2099.
98. Marette, A., Mauriege, P., Marcotte, B. et al. 1997. Regional variation in adipose tissue insulin action and GLUT4 glucose transporter expression in severely obese premenopausal women. Diabetologia 40, 590-598.
99. Margetic, S., Gazzola, C., Pegg, G.G. & Hill, R.A. 2002. Leptin: a review of its peripheral actions and interactions. Int J Obes Relat Metab Disord 26, 1407-1433.
100. Martin, M.L. & Jensen, M.D. 1991. Effects of body fat distribution on regional lipolysis in obesity. J Clin Invest 88, 609-613.
101. Matsumoto, M., Ogawa, W., Teshigawara, K. et al. 2002. Role of the insulin receptor substrate 1 and phosphatidylinositol 3-kinase signaling pathway in insulin-induced expression of sterol regulatory element binding protein 1c and glucokinase genes in rat hepatocytes. Diabetes 51, 1672-1680.
102. Mauriege, P., Galitzky, J., Berlan, M. & Lafontan, M. 1987. Heterogeneous distribution of beta and alpha-2 adrenoceptor binding sites in human fat cells from various fat deposits: functional consequences. EurJ Clin Invest 17, 156-165.
103. Montague, C.T. & O'Rahilly, S. 2000. The perils of portliness: causes and consequences of visceral adiposity. Diabetes 49, 883-888.
104. Montague, C.T., Farooqi, I.S., Whitehead, J.P, et al. 1997. Congenital leptin deficiency is associated with severe early-onset obesity in humans. Nature 387, 903-908.
105. Montague, C.T., Prins, J.B., Sanders, L. et al. 1998. Depot-related gene expression in human subcutaneous and omental adipocytes. Diabetes 47, 1384-1391.
106. Motoshima, H., Wu, X., Sinha, M.K. et al. 2002. Differential regulation of adiponectin secretion from cultured human omental and subcutaneous adipocytes: effects of insulin and rosiglitazone. J Clin Endocrinol Metab 87, 5662-5667.
107. Nishizawa, H., Shimomura, I., Kishida, K. et al. 2002. Androgens decrease plasma adiponectin, an insulin-sensitizing adipocyte-derived protein. Diabetes 51, 2734-2741.
108. Nosadini, R., Del Prato, S., Tiengo, A. et al. 1983. Insulin resistance in Cushing's syndrome. J Clin Endocrinol Metab 57, 529-536.
109. Ogg, S. & Ruvkun, G. 1998. The C. elegans PTEN homolog, DAF-18, acts in the insulin receptor-like metabolic signaling pathway. Mol Cell 2, 887-893.
110. Ohlson, L.O., Larsson, B., Svardsudd, K. et al. 1985. The influence of body fat distribution on the incidence of diabetes mellitus. 13.5 years of follow-up of the participants in the study of men born in 1913. Diabetes 34, 1055-1058.
111. Okada, T., Kawano, Y., Sakakibara, T., Hazeki, O. & Ui, M. 1994. Essential role of phosphatidylinositol 3-kinase in insulin-induced glucose transport and antilipolysis in rat adipocytes. Studies with a selective inhibitor wortmannin. J Biol Chem 269, 3568-3573.
112. Olson, A.L., Trumbly, A.R. & Gibson, G.V. 2001. Insulin-mediated GLUT4 translocation is dependent on the microtubule network. J Biol Chem 276, 10706-10714.
113. Olswang, Y., Cohen, H., Papo, O. et al. 2002. A mutation in the peroxisome proliferator-activated receptor gamma-binding site in the gene for the cytosolic form of phosphoenolpyruvate carboxykinase reduces adipose tissue size and fat content in mice. Proc Natl Acad Sci USA 99, 625-630.
114. Onuma, H., Osawa, H., Yamada, K. et al. 2002. Identification of the insulin-regulated interaction of phosphodiesterase 3B with 14-3-3 beta protein. Diabetes 51, 3362-3367.
115. Pagano, G., Cavallo-Perin, P., Cassader, M. et al. 1983. An in vivo and in vitro study of the mechanism of prednisone-induced insulin resistance in healthy subjects. J Clin Invest 72, 1814-1820.
116. Paulauskis, J.D. & Sul, H.S. 1988. Cloning and expression of mouse fatty acid synthase and other specific mRNAs. Developmental and hormonal regulation in 3T3-L1 cells. J Biol Chem 263, 7049-7054.
117. Paulauskis, J.D. & Sul, H.S. 1989. Hormonal regulation of mouse fatty acid synthase gene transcription in liver. J Biol Chem 264, 574-577.
118. Pelicci, G., Lanfrancone, L., Grignani, F. et al. 1992. A novel transforming protein (SHC) with an SH2 domain is implicated in mitogenic signal transduction. Cell 70, 93-104.
119. Perrini, S., Laviola, L., Belsanti, G. et al. 2003. Insulin signaling in human adipose tissue depots in vivo. Diabetes 52(Suppl. 1), A309.
120. Perrini, S., Natalicchio, A., Laviola, L. et al. 2004. Dehydroepiandrosterone stimulates glucose uptake in human and murine adipocytes by inducing GLUT1 and GLUT4 translocation to the plasma membrane. Diabetes 53, 41-52.
121. Peterson, R.T. & Schreiber, S.L. 1999. Kinase phosphorylation: Keeping it all in the family. Curr Biol 9, R521-R524.
122. Pickup, J.C., Chusney, G.D., Thomas, S.M. & Burt, D. 2000. Plasma interleukin-6, tumour necrosis factor alpha and blood cytokine production in type 2 diabetes. Life Sci 67, 291-300.
123. Prusty, D., Park, B.H., Davis, K.E. & Farmer, S.R. 2002. Activation of MEK/ERK signaling promotes adipogenesis by enhancing peroxisome proliferator-activated receptor gamma (PPARgamma) and C/EBPalpha gene expression during the differentiation of 3T3-L1 preadipocytes. J Biol Chem 277, 46226-46232.
124. Rask, E., Olsson, T., Soderberg, S. et al. 2001. Tissue-specific dysregulation of cortisol metabolism in human obesity. J Clin Endocrinol Metab 86, 1418-1421.
125. Rea, S. & James, D.E. 1997. Moving GLUT4: the biogenesis and trafficking of GLUT4 storage vesicles. Diabetes 46, 1667-1677.
126. Rebuffe-Scrive, M., Andersson, B., Olbe, L. & Bjorntorp, P. 1989. Metabolism of adipose tissue in intraabdominal depots of nonobese men and women. Metabolism 38, 453-458.
127. Ribaux, P.G. & Iynedjian, P.B. 2003. Analysis of the role of protein kinase B (cAKT) in insulin-dependent induction of glucokinase and sterol regulatory element-binding protein 1 (SREBP1) mRNAs in hepatocytes. Biochem J 376, 697-705.
128. Ribon, V., Herrera, R., Kay, B.K. & Saltiel, A.R. 1998a. A role for CAP, a novel, multifunctional Src homology 3 domain-containing protein in formation of actin stress fibers and focal adhesions. J Biol Chem 273, 4073-4080.
129. Ribon, V., Johnson, J.H., Camp, H.S. & Saltiel, A.R. 1998b. Thiazolidinediones and insulin resistance: peroxisome proliferatoractivated receptor gamma activation stimulates expression of the CAP gene. Proc Natl Acad Sci USA 95, 14751-14756.
130. Roden, M., Price, T.B., Perseghin, G. et al. 1996. Mechanism of free fatty acid-induced insulin resistance in humans. J Clin Invest 97, 2859-2865.
131. Romsos, D.R. & Leveille, G.A. 1974. Effect of diet on activity of enzymes involved in fatty acid and cholesterol synthesis. Adv Lipid Res 12, 97-146.
132. de Ronde, W., Pols, H.A., van Leeuwen, J.P. & de Jong, F.H. 2003. The importance of oestrogens in males. Clin Endocrinol (Oxf) 58, 529-542.
133. Rosen, E.D. & Spiegelman, B.M. 2001. PPARgamma: a nuclear regulator of metabolism, differentiation, and cell growth. J Biol Chem 276, 37731-37734.
134. Rosenbaum, M., Malbon, C.C., Hirsch, J. & Leibel, R.L. 1993. Lack of beta 3-adrenergic effect on lipolysis in human subcutaneous adipose tissue. J Clin Endocrinol Metab 77, 352-355.
135. Rosenbaum, M., Nicolson, M., Hirsch, J., Murphy, E., Chu, F. & Leibel, R.L. 1997. Effects of weight change on plasma leptin concentrations and energy expenditure. J Clin Endocrinol Metab 82, 3647-3654.
136. Roth, G., Kotzka, J., Kremer, L. et al. 2000. MAP kinases Erk1/2 phosphorylate sterol regulatory element-binding protein (SREBP)-1a at serine 117 in vitro. J Biol Chem 275, 33302-33307.
137. Rotter, V., Nagaev, I. & Smith, U. 2003. Interleukin-6 (IL-6) induces insulin resistance in 3T3-L1 adipocytes and is, like IL-8 and tumor necrosis factor-alpha, overexpressed in human fat cells from insulin-resistant subjects. J Biol Chem 278, 45777-45784.
138. Salans, L.B., Cushman, S.W. & Weismann, R.E. 1973. Studies of human adipose tissue. Adipose cell size and number in nonobese and obese patients. J Clin Invest 52, 929-941.
139. Scherer, P.E., Williams, S., Fogliano, M., Baldini, G. & Lodish, H.F. 1995. A novel serum protein similar to C1q, produced exclusively in adipocytes. J Biol Chem 270, 26746-26749.
140. Schoonjans, K., Peinado-Onsurbe, J., Lefebvre, A. et al. 1996. PPARalpha and PPARgamma activators direct a distinct tissue-specific transcriptional response via a PPRE in the lipoprotein lipase gene. EMBO J 15, 5336-5348.
141. Sethi, J.K. & Hotamisligil, G.S. 1999. The role of TNF alpha in adipocyte metabolism. Semin Cell Dev Biol 10, 19-29.
142. Shimomura, I., Bashmakov, Y., Ikemoto, S., Horton, J.D., Brown, M.S. & Goldstein J.L. 1999. Insulin selectively increases SREBP-1c mRNA in the livers of rats with streptozotocin-induced diabetes. Proc Natl Acad Sci USA 96, 13656-13661.
143. Smith, C.J. & Manganiello, V.C. 1989. Role of hormone-sensitive low Km cAMP phosphodiesterase in regulation of cAMP-dependent protein kinase and lipolysis in rat adipocytes. Mol Pharmacol 35, 381-386.
144. Smith, U., Carvalho, E., Mosialou, E., Beguinot, F., Formisano, P. & Rondinone C. 2000. PKB inhibition prevents the stimulatory effect of insulin on glucose transport and protein translocation but not the antilipolytic effect in rat adipocytes. Biochem Biophys Res Commun 268, 315-320.
145. Soncini, M., Yet, S.F., Moon, Y., Chun, J.Y. & Sul, H.S. 1995. Hormonal and nutritional control of the fatty acid synthase promoter in transgenic mice. J Biol Chem 270, 30339-30343.
146. Sopasakis, V.R., Sandqvist, M., Gustafson, B. et al. 2004. High local concentrations and effects on differentiation implicate interleukin-6 as a paracrine regulator. Obes Res 12, 454-460.
147. Spranger, J., Kroke, A., Mohlig, M. et al. 2003. Adiponectin and protection against type 2 diabetes mellitus. Lancet 361, 226-228.
148. Standaert, M.L., Galloway, L., Karnam, P., Bandyopadhyay, G., Moscat, J. & Farese, R.V. 1997. Protein kinase C-ζ as a downstream effector of phosphatidylinositol 3-kinase during insulin stimulation in rat adipocytes. J Biol Chem 272, 30075-30082.
149. Standaert, M.L., Bandyopadhyay, G., Perez, L. et al. 1999. Insulin activates protein kinases C-zeta and C-lambda by an autophosphorylation- dependent mechanism and stimulates their translocation to GLUT4 vesicles and other membrane fractions in rat adipocytes. J Biol Chem 274, 25308-25316.
150. Stolic, M., Russell, A., Hutley, L. et al. 2002. Glucose uptake and insulin action in human adipose tissue-influence of BMI, anatomical depot and body fat distribution. Int J Obes Relat Metab Disord 26, 17-23.
151. Stralfors, P. & Belfrage, P. 1983. Phosphorylation of hormone-sensitive lipase by cyclic AMP-dependent protein kinase. J Biol Chem 258, 15146-15152.
152. Stralfors, P. & Honnor, R.C. 1989. Insulin-induced dephosphorylation of hormone-sensitive lipase. Correlation with lipolysis and cAMP-dependent protein kinase activity. Eur J Biochem 182, 379-385.
153. Sun, X.J., Miralpeix, M., Myers, M.G. Jr et al. 1992. Expression and function of IRS-1 in insulin signal transmission. J. Biol. Chem 267, 22662-22672.
154. Sun, X.J., Wang, L.M., Zhang, Y. et al. 1995. Role of IRS-2 in insulin and cytokine signalling. Nature 377, 173-177.
155. Svedberg, J., Bjorntorp, P., Smith, U. & Lonnroth, P. 1990. Free-fatty acid inhibition of insulin binding, degradation, and action in isolated rat hepatocytes. Diabetes 39, 570-574.
156. Tanti, J.F., Grillo, S., Gremeaux, T. et al. 1997. Potential role of protein kinase B in glucose transporter 4 translocation in adipocytes. Endocrinology 138, 2005-2010.
157. Thorne, A., Lonnqvist, F., Apelman, J., Hellers, G. & Arner, P. 2002. A pilot study of long-term effects of a novel obesity treatment: omentectomy in connection with adjustable gastric banding. Int J Obes Relat Metab Disord 26, 193-199.
158. Tontonoz, P., Hu, E., Devine, J., Beale, E. & Spiegelman B. (1995) PPAR-γ2 regulates adipose expression of the phosphoenolpyruvate carboxykinase gene. Mol Cell Biol 15, 351-357.
159. Tschritter, O., Fritsche, A., Thamer, C. et al. 2003. Plasma adiponectin concentrations predict insulin sensitivity of both glucose and lipid metabolism. Diabetes 52, 239-243.
160. Turnbull, A.V. & Rivier, C.L. 1999. Regulation of the hypothalamic-pituitary-adrenal axis by cytokines: actions and mechanisms of action. Physiol Rev 79, 1-71.
161. Uysal, K.T., Wiesbrock, S.M., Marino, M.W. & Hotamisligil, G.S. 1997. Protection from obesity-induced insulin resistance in mice lacking TNF-alpha function. Nature 389, 610-614.
162. Van Harmelen, V., Lonnqvist, F., Thorne, A. et al. 1997. Noradrenaline-induced lipolysis in isolated mesenteric, omental and subcutaneous adipocytes from obese subjects. Int J Obes Relat Metab Disord 21, 972-979.
163. Van Harmelen, V., Reynisdottir, S., Cianflone, K. et al. 1999. Mechanisms involved in the regulation of free fatty acid release from isolated human fat cells by acylation-stimulating protein and insulin. J Biol Chem 274, 18243-18251.
164. Van Weeren, P.C., de Bruyn, K.M.T., de Vries-Smits, A.M.M., van Lint, J. & Burgering, B.M.T. 1998. Essential role for protein kinase B (PKB) in insulin-induced glycogen synthase kinase 3 inactivation. J Biol Chem 273, 13150-13156.
165. Vidal-Puig, A.J., Considine, R.V., Jimenez-Linan, M. et al. 1997. Peroxisome proliferator-activated receptor gene expression in human tissues. Effects of obesity, weight loss, and regulation by insulin and glucocorticoids. J Clin Invest 99, 2416-2422.
166. Vikman, H.L., Savola, J.M., Raasmaja, A. & Ohisalo, J.J. 1996. Alpha 2A-adrenergic regulation of cyclic AMP accumulation and lipolysis in human omental and subcutaneous adipocytes. Int J Obes Relat Metab Disord 20, 185-189.
167. Virkamaki, A., Ueki, K. & Kahn, C.R. 1999. Protein-protein interaction in insulin signaling and the molecular mechanisms of insulin resistance. J Clin Invest 103, 931-943.
168. Virtanen, K.A., Lonnroth, P., Parkkola, R. et al. 2002. Glucose uptake and perfusion in subcutaneous and visceral adipose tissue during insulin stimulation in nonobese and obese humans. J Clin Endocrinol Metab 87, 3902-3910.
169. Virtanen, K.A., Hallsten, K., Parkkola, R. et al. 2003. Differential effects of rosiglitazone and metformin on adipose tissue distribution and glucose uptake in type 2 diabetic subjects. Diabetes 52, 283-290.
170. Wada, T., Sasaoka, T., Ishiki, M. et al. 1999. Role of the Src homology 2 (SH2) domain and C-terminus tyrosine phosphorylation sites of SH2-containing inositol phosphatase (SHIP) in the regulation of insulin-induced mitogenesis. Endocrinology 140, 4585-4594.
171. Wada, T., Sasaoka, T., Funaki, M. et al. 2001. Overexpression of SH2-containing inositol phosphatase 2 results in negative regulation of insulin-induced metabolic actions in 3T3-L1 adipocytes via its 5′-phosphatase catalytic activity. Mol Cell Biol 21, 1633-1646.
172. Wajchenberg, B.L., Giannella-Neto, D., da Silva, M.E. & Santos, R.F. 2002. Depot-specific hormonal characteristics of subcutaneous and visceral adipose tissue and their relation to the metabolic syndrome. Horm Metab Res 34, 616-621.
173. Walczak, R. & Tontonoz, P. 2002. PPARadigms and PPAR-adoxes: expanding roles for PPARgamma in the control of lipid metabolism. J Lipid Res 43, 177-186.
174. Walker, B.R. 2004. Is "Cushing's disease of the omentum" an affliction of mouse and men? Diabetologia 47, 767-769.
175. Wallenius, V., Wallenius, K., Ahren, B. et al. 2002a. Interleukin-6-deficient mice develop mature-onset obesity. Nat Med 8, 75-79.
176. Wallenius, K., Wallenius, V., Sunter, D., Dickson, S.L. & Jansson, J.O. 2002b. Intracerebroventricular interleukin-6 treatment decreases body fat in rats. Biochem Biophys Res Commun 293, 560-565.
177. Wang, D. & Sul, H.S. 1998. Insulin stimulation of the fatty acid synthase promoter is mediated by the phosphatidylinositol 3-kinase pathway. Involvement of protein kinase B/ Akt. J Biol Chem 273, 25420-25426.
178. Wang, Q., Bilan, P.J., Tsakiridis, T., Hinek, A. & Klip, A. 1998. Actin filaments participate in the relocalization of phosphatidylinositol3- kinase to glucose transporter-containing compartments and in the stimulation of glucose uptake in 3T3-L1 adipocytes. Biochem J 331, 917-928.
179. Weyer, C., Foley, J.E., Bogardus, C., Tataranni, P.A. & Pratley, R.E. 2000. Enlarged subcutaneous abdominal adipocyte size, but not obesity itself, predicts type II diabetes independent of insulin resistance. Diabetologia 43, 1498-1506.
180. Weyer, C., Funahashi, T., Tanaka, S. et al. 2001. Hypoadiponectinemia in obesity and type 2 diabetes: close association with insulin resistance and hyperinsulinemia. J Clin Endocrinol Metab 86, 1930-1935.
181. Whiteman, E.L., Cho, H. & Birnbaum, M.J. 2002. Role of Akt/protein kinase B in metabolism. Trends Endocrinol Metab 13, 444-451.
182. Williams, L.B., Fawcett, R.L., Waechter, A.S. et al. 2000. Leptin production in adipocytes from morbidly obese subjects: stimulation by dexamethasone, inhibition with troglitazone, and influence of gender. J Clin Endocrinol Metab 85, 2678-2684.
183. Wu, Z., Xie, Y., Morrison, R.F., Bucher, N.L.R. & Farmer, S.R. 1998. PPARgamma induces the insulin-dependent glucose transporter GLUT4 in the absence of C/EBPalpha during the conversion of 3T3 fibroblasts into adipocytes. J Clin Invest 101, 22-32.
184. Yanase, T., Yashiro, T., Takitani, K. et al. 1997. Differential expression of PPAR gamma1 and gamma2 isoforms in human adipose tissue. Biochem Biophys Res Commun 233, 320-324.
185. Yudkin, J.S., Stehouwer, C.D., Emeis, J.J. & Coppack, S.W. 1999. C-reactive protein in healthy subjects: associations with obesity, insulin resistance, and endothelial dysfunction: a potential role for cytokines originating from adipose tissue? Arterioscler Thromb Vasc Biol 19, 972-978.
186. Zhang, Y., Proenca, R., Maffei, M., Barone, M., Leopold, L. & Friedman, J.M. 1994. Positional cloning of the mouse obese gene and its human homologue. Nature 372, 425-432.
187. Zhang, B., Berger, J., Zhou, G. et al. 1996. Insulin- and mitogen-activated protein kinase-mediated phosphorylation and activation of peroxisome proliferator-activated receptor gamma. J Biol Chem 271, 31771-31774.
188. Zierath, J.R., Livingston, J.N., Thorne, A. et al. 1998. Regional difference in insulin inhibition of non-esterified fatty acid release from human adipocytes: relation to insulin receptor phosphorylation and intracellular signalling through the insulin receptor substrate-1 pathway. Diabetologia 41, 1343-1354.